Michal Uher

979 total citations
88 papers, 736 citations indexed

About

Michal Uher is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Michal Uher has authored 88 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Organic Chemistry, 14 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Michal Uher's work include Synthesis and Characterization of Heterocyclic Compounds (14 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (11 papers) and Synthesis and biological activity (10 papers). Michal Uher is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (14 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (11 papers) and Synthesis and biological activity (10 papers). Michal Uher collaborates with scholars based in Slovakia, Czechia and Poland. Michal Uher's co-authors include Július Brtko, Daniela Hudecová, M Ficková, Jakub Závada, Jiří Vencovský, Soňa Jantová, Milan Melnı́k, Karel Pavelká, Ladislav Novotný and L Rondahl and has published in prestigious journals such as Scientific Reports, Carbohydrate Polymers and Annals of the Rheumatic Diseases.

In The Last Decade

Michal Uher

77 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michal Uher Slovakia 15 281 181 92 92 87 88 736
Keiko Kuroda Japan 18 268 1.0× 254 1.4× 237 2.6× 22 0.2× 97 1.1× 63 1.0k
Jacques Yves Gauthier Canada 21 698 2.5× 432 2.4× 50 0.5× 24 0.3× 115 1.3× 44 1.3k
Jianqing Li United States 18 655 2.3× 265 1.5× 77 0.8× 68 0.7× 151 1.7× 58 1.1k
Mi Yan China 12 393 1.4× 296 1.6× 25 0.3× 16 0.2× 26 0.3× 21 866
Katarzyna Kotwica-Mojzych Poland 16 416 1.5× 188 1.0× 9 0.1× 44 0.5× 49 0.6× 37 749
Fedor N. Novikov Russia 14 157 0.6× 348 1.9× 32 0.3× 15 0.2× 45 0.5× 43 803
Blaine M. Sutton United Kingdom 14 451 1.6× 174 1.0× 92 1.0× 12 0.1× 54 0.6× 34 963
Dirk A. Bornemeier United States 10 424 1.5× 217 1.2× 49 0.5× 8 0.1× 25 0.3× 14 747
Vanessa Desplat France 20 683 2.4× 323 1.8× 26 0.3× 11 0.1× 93 1.1× 52 1.2k
Guisen Zhao China 18 490 1.7× 537 3.0× 24 0.3× 16 0.2× 43 0.5× 58 1.1k

Countries citing papers authored by Michal Uher

Since Specialization
Citations

This map shows the geographic impact of Michal Uher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Uher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Uher more than expected).

Fields of papers citing papers by Michal Uher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Uher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Uher. The network helps show where Michal Uher may publish in the future.

Co-authorship network of co-authors of Michal Uher

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Uher. A scholar is included among the top collaborators of Michal Uher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Uher. Michal Uher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Staník, Michal, Ondřej Ngo, Karel Hejduk, et al.. (2025). ProstaPilot: A Comparative Study of Biparametric Magnetic Resonance Imaging Versus Prostate-specific Antigen as a Screening Test for Prostate Cancer. European Urology Open Science. 76. 7–13.
2.
Rohan, Tomáš, et al.. (2025). Prognostic factors for survival in patients with advanced cholangiocarcinoma treated with percutaneous transhepatic drainage. Scientific Reports. 15(1). 2172–2172. 1 indexed citations
3.
Marcke, Cédric van, Kristin Pogoda, Michael Borges, et al.. (2024). 141P The causes and consequences of incomplete paclitaxel administration during the neoadjuvant treatment of early triple-negative and HER2 positive breast cancer (CIPNETH). ESMO Open. 9. 103128–103128. 1 indexed citations
4.
Uher, Michal, et al.. (2023). Changes in Segmental Impedances and Selected Body Composition Parameters Assessed by Multi-Frequency Bioimpedance Analysis after Fluid Consumption in Healthy Young Population. International Journal of Medical Sciences. 20(13). 1783–1790. 3 indexed citations
5.
Zádorová, Zdena, et al.. (2019). Vitamin D supplementation dose needs to be higher in patients with inflammatory bowel disease: interventional study. Vnitřní lékařství. 65(7-8). 470–474. 10 indexed citations
6.
Uher, Michal, et al.. (2019). Uveal melanoma - testing of abnormalities of chromosome 3 and 8 in the Czech Republic. Biomedical Papers. 164(4). 401–409. 1 indexed citations
7.
Šumová, Barbora, Lucie Andrés Cerezo, Michal Uher, et al.. (2018). Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study. Rheumatology International. 39(3). 469–478. 26 indexed citations
8.
Závada, Jakub, Petra Hánová, Michal Uher, et al.. (2017). The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis – a cohort study. Arthritis Research & Therapy. 19(1). 5–5. 15 indexed citations
9.
Fráňová, Jana, et al.. (2016). Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration. Pediatric Rheumatology. 14(1). 36–36. 30 indexed citations
10.
Závada, Jakub, Michal Uher, Marta Olejarová, et al.. (2015). Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study. Arthritis Research & Therapy. 17(1). 341–341. 16 indexed citations
13.
Synytsya, Andriy, et al.. (2007). Conjugation of kojic acid with chitosan. Carbohydrate Polymers. 72(1). 21–31. 41 indexed citations
14.
Rondahl, L, Michal Uher, & Július Brtko. (2003). SYNTHESES AND STRUCTURE DETERMINATIONS OF SOME SELENOCYANATO- AND THIOCYANATO-KOJIC ACID DERIVATIVES. Heterocyclic Communications. 9(3). 257–258. 5 indexed citations
15.
Wójtowicz‐Rajchel, Hanna, Jacek Młochowski, Jerzy Palus, et al.. (2003). Functionalized alkyl and aryl diselenides as antimicrobial and antiviral agents: synthesis and properties. Il Farmaco. 58(12). 1235–1242. 35 indexed citations
16.
Hudecová, Daniela, Soňa Jantová, Milan Melnı́k, & Michal Uher. (1996). New azidometalkojates and their biological activity. Folia Microbiologica. 41(6). 473–476. 44 indexed citations
17.
Brtko, Július, et al.. (1995). Antileukemic activity of 4-pyranone derivatives. The International Journal of Biochemistry & Cell Biology. 27(7). 701–706. 32 indexed citations
18.
Végh, Daniel, et al.. (1993). Preparation of vic-Mercaptoisopentanols. Collection of Czechoslovak Chemical Communications. 58(2). 404–408. 1 indexed citations
19.
Uher, Michal, et al.. (1976). Reaction of isothiocyanates with diazomethane. Collection of Czechoslovak Chemical Communications. 41(4). 1182–1187. 5 indexed citations
20.
Uher, Michal, et al.. (1963). [CHANGES IN ELECTRICAL IRRITABILITY IN THE ZACHARJIN-HEAD ZONES DURING LABOR].. PubMed. 28. 486–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026